Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze

Drug Development Research

Volumn 46, Issue 2, 1999, Pages 107-111

  Levin, Edward D ^a   Imad Damaj, M ^b   Glassco, William ^b   May, Everett L ^b   Martin, Billy R ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholinergic; Nicotinic; Radial arm maze

Indexed keywords

ISONICOTINE; NICOTINE; NICOTINE DERIVATIVE; NORISONICOTINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; FEMALE; MAZE TEST; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; WORKING MEMORY;

EID: 0345161599     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199902)46:2<107::AID-DDR3>3.0.CO;2-C     Document Type: Article

References (16)

1. Arendash GW, Sengstock GJ, Sanberg PR, Kem WR. 1995. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674:252-259.
2. Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP 1995. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology 120:256-266.
3. Damaj MI, Glassco W, Marks MJ, Slobe B, James JR, May EL, Rosecrans JA, Collins AC, Martin BR. 1997. Pharmacological investigation of (+)-and (-)-cis-2,3,3a,4,5,9bhexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoquinoline, a bridged-nicotine analog. J Pharmacol Exp Ther 282:1425-1434.
4. Decker MW, Majchrzak MJ, Arneric SP. 1993. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol Biochem Behav 45:571-576.
5. Decker MW, Curzon P, Brioni JD, Arneric SP. 1994. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septallesioned rats. Eur J Pharmacol 261:217-222.
6. Decker MW, Brioni JD, Bannon AW, Arneric SP. 1995. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics-minireview. Life Sci 56:545-570.
7. Felix R, Levin ED. 1997. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81:1009-1017.
8. Glassco W, Suchocki J, George C, Martin BR, May EL. 1993. Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)-and (-)-cis-2,3,3a,4,5,9bhexahydro-1-methyl-1H-pyrrolo[3,2-h]isoquinoline, a structural analog of nicotine. J Med Chem 36:3381-3385, 1993.
9. Glassco W, May EL, Weaver V, Damaj MI, Rosecrans J, Martin BR. Pharmacological investigation of N-substituted derivatives of (±)-norisonicotine. Med Chem Res 4:474-482, 1994.
10. Keppel G. 1973. Design and analysis: a researcher's handbook. Englewood Cliffs, NJ: Prentice-Hall, Inc.
11. Ksir C. 1994. Acute and chronic nicotine effects on measures of activity in rats: a multivariate analysis. Psychopharmacology 115:105-109.
12. Levin ED, Simon BB. 1998. Nicotinic acetylcholine involvement in cognitive function in animals. Pyschopharmacology 138:217-230.
13. Levin ED, Rose JE, Abood L. 1995. Effects of nicotinic dimethyl-aminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmacol Biochem Behav 51:369-373.
14. Levin E, Kaplan S, Boardman A. 1997. Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. Behav Pharmacol 8:236-242, 1997.
15. Stolerman IP, Garcha HS, Mirza NR. 1995. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology 117:430-437.
16. Woodruff-Pak DS, Li YT, Kem WR. 1994. A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res 645:309-317.